Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-877-8 | CAS number: 3266-23-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD), but non-GLP; restriction: E. coli not tested
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 4 strains tested
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,3-epoxybutane
- EC Number:
- 221-877-8
- EC Name:
- 2,3-epoxybutane
- Cas Number:
- 3266-23-7
- Molecular formula:
- C4H8O
- IUPAC Name:
- 2,3-dimethyloxirane
- Details on test material:
- - Name of test material (as cited in study report): n-Butylenoxid-2,3
- Test substance No.: 88/978
- Storage condition of test material: room temperature
Constituent 1
Method
- Target gene:
- several S. typhimurium strains
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- 20, 100, 500, 2500 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: with S-9 mix: 2-aminoanthracene; without S-9 mix: N-methyl-N'-nitro-Nnitroso-guanidine, 4-nitro-o-phenylenediamine and 9-aminoacridine chloride monohydrate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h, 37°C
NUMBER OF REPLICATIONS: 3 test plates per dose or per control - Evaluation criteria:
- In general, a substance to be characterized as positive in the Ames test has to fulfill the following requirements:
- doubling of the spontaneous mutation rate (control)
- dose-response relationship
- reproducibility of the results
Results and discussion
Test results
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- ambiguous
- Remarks:
- weakly positive for TA 100 and TA 1535 at >2500 µg/plate
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Results:
metabolic activation | TA98 | TA100 | TA1535 | TA1537 | TA1535 (trail 2) | TA1535 (trail 3) | ||||||||||||
Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | Trial 1 | Trial 2 | Trial 3 | |
+ | 33 | 34 | 35 | 124 | 95 | 129 | 19 | 24 | 24 | 12 | 10 | 15 | 32 | 29 | 26 | 22 | 23 | 23 |
+ | 38 | 45 | 29 | 144 | 120 | 127 | 38 | 30 | 33 | 17 | 13 | 14 | 69 | 65 | 62 | 25 | 27 | 20 |
+ | 45 | 42 | 36 | 117 | 138 | 138 | 22 | 32 | 37 | 8 | 14 | 24 | 26 | 22 | 28 | 31 | 36 | 22 |
+ | 42 | 32 | 41 | 138 | 112 | 142 | 27 | 36 | 38 | 15 | 19 | 14 | 121 | 97 | 83 | 26 | 32 | 23 |
+ | 42 | 31 | 34 | 259 | 218 | 191 | 86 | 73 | 68 | 11 | 13 | 13 | 37 | 37 | 35 | 53 | 67 | 38 |
+ | 44 | 37 | 37 | 241 | 253 | 244 | 112 | 100 | 114 | 15 | 14 | 11 | 37 | 45 | 39 | 102 | 80 | 93 |
+ | 1150 | 1090 | 140 | 1500 | 1400 | 1460 | 125 | 133 | 131 | 177 | 182 | 146 | 1035 | 936 | 1015 | 660 | 960 | 680 |
- | 30 | 32 | 34 | 90 | 99 | 116 | 13 | 20 | 24 | 10 | 14 | 12 | 23 | 25 | 27 | 21 | 27 | 19 |
- | 34 | 22 | 24 | 107 | 98 | 110 | 25 | 27 | 35 | 12 | 7 | 12 | 41 | 22 | 31 | 30 | 19 | 24 |
- | 27 | 29 | 38 | 140 | 116 | 129 | 36 | 38 | 35 | 9 | 8 | 12 | 37 | 41 | 45 | 19 | 11 | 26 |
- | 36 | 30 | 40 | 132 | 126 | 145 | 50 | 44 | 33 | 14 | 15 | 9 | 49 | 32 | 47 | 34 | 23 | 26 |
- | 47 | 40 | 31 | 168 | 180 | 172 | 70 | 66 | 69 | 11 | 17 | 9 | 52 | 49 | 42 | 61 | 57 | 46 |
- | 35 | 37 | 32 | 296 | 238 | 203 | 162 | 127 | 90 | 23 | 18 | 15 | 60 | 56 | 80 | 68 | 73 | 75 |
- | 1630 | 1650 | 1470 | 2100 | 2200 | 2250 | 795 | 895 | 925 | |||||||||
- | 670 | 760 | 850 | |||||||||||||||
- | ||||||||||||||||||
- | 506 | 518 | 614 |
Tests without S-9 mix:
TA 1535: Weakly positive reaction from about 100 µg/plate (factor 1.6 - 1.9 in the 1st and 2nd experiments) or from about 2500 µg/plate (factor 2.4; 3rd experiment) onward. Increase in the number of his+ revertants at 5000 µg/ plate by a factor of 2.8 - 6.6
TA 100: Weakly positive effect at 2500 µg - 5000 µg/plate
TA 1537, TA 98: No increase in the number of his + revertants
Tests with S-9 mix:
TA 1535: Mutagenicity was observed in the 1st and 3rd study at doses > 2500 µg/plate (factor 2.3 - 4.9). In the 2nd experiment increased values were found which did not show a dose-dependent effect.
TA 100: Weakly positive reaction at 2500 µg (factor 1.9) and 5000 µg (factor 2.1)
TA 1537, TA 98: No increase in the number of his+ revertants
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
ambiguous
According to the results of this study, n-Butylenoxid-2,3 is weakly mutagenic in the Ames test under the experimental conditions chosen here.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.